Bio-Rad Laboratories, Inc. Dividend History (BIO)
Bio-Rad Laboratories, Inc. does not pay dividends currently 😔
They might in the future, check back soon!
About Bio-Rad Laboratories, Inc.
Bio-Rad Laboratories, Inc. is a renowned global leader in the life sciences and clinical diagnostics industries. Founded in 1952 by David and Alice Schwartz, the company is headquartered in Hercules, California. Bio-Rad develops, manufactures, and markets a wide range of innovative products and solutions that are essential for scientific research, drug discovery, and clinical diagnostics. As of 2023, the CEO is Norman Schwartz, a member of the founding family. The company is known for its commitment to quality and innovation, playing a vital role in advancing scientific discoveries and improving healthcare outcomes. Bio-Rad actively serves hospitals, universities, research facilities, and pharmaceutical companies around the world, generating substantial annual revenue, which was approximately $2.8 billion in recent years.
The global flow cytometry market is expected to grow from $6.38 billion in 2024 to $12.66 billion by 2034, driven by technological advancements and expanding applications. The USA, Germany, China, and India are expected to see strong growth in this market.
GlobeNewswire Inc. · Published on Thu Dec 05 2024The newborn screening market is projected to grow at a CAGR of 6.8% from 2024 to 2031, driven by the rising prevalence of congenital disorders and technological advancements in screening methodologies.
GlobeNewswire Inc. · Published on Wed Dec 04 2024The global sample preparation market is expected to grow at a CAGR of 6.4% by 2031, driven by technological advancements in specimen collection and preparation. The consumables segment and solid-phase extraction technique are expected to lead the market growth.
Benzinga · Published on Mon Dec 02 2024